The Holy Family High Specialty Hospital
The Holy Family High Specialty Hospital
Poland, Rzeszow
Bozena Salata
36 years of experience
Clinic is certified :
Parkinson's disease treatment cost in Poland is primarily determined by the chosen therapeutic approach and disease stage. Diagnostic procedures like a brain MRI with contrast typically range from $200 to $300. Major surgical interventions, such as deep brain stimulation (DBS), run from $30,000 to $45,000. Patients can expect savings of 40-60% compared to the US. Top destinations for care include Warsaw, Krakow, and Rzeszow.
Typical Parkinson's Disease Treatment Costs in Poland
Bookimed Expert Insight: For advanced cases, large university centers provide the most comprehensive surgical value. University Hospital in Krakow serves 455,000 patients annually with excellent technical equipment. Patients focused on neurological rehabilitation should consider specialized private clinics. The Holy Family High Specialty Hospital is highly rated for rehabilitation services. This facility belongs to GVM Care & Research, a major European healthcare group. Their multidisciplinary approach ensures stable long-term management for international patients.
| Poland | Turkey | Austria | |
| Medication treatment for Parkinson's disease | from $1,800 | from $1,000 | from $2,000 |
| Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) | from $12,500 | from $10,000 | from $16,000 |
| Deep brain stimulation (DBS) surgery | from $30,000 | from $23,000 | from $45,000 |
| Stem cell therapy for Parkinson's disease | from $20,000 | from $25,000 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Parkinson's disease treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Parkinson's disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Parkinson's disease treatment journey.
Written by Kateryna Zamkovska
Primary Parkinson’s treatments in Poland include pharmacological therapy, Deep Brain Stimulation (DBS), and device-aided infusion pumps. Specialist centers in Warsaw and Krakow provide advanced options like MR-guided focused ultrasound (MRgFUS). Early-stage care focuses on levodopa dosing and dopaminergic medications to manage motor symptoms effectively.
Bookimed Expert Insight: University Hospital in Krakow serves a massive volume of 455,000 patients annually. This scale allows for highly specialized multidisciplinary teams that are rare in smaller clinics. Patients seeking complex DBS or device-aided therapies benefit from this concentrated expertise in major medical hubs.
Patient Consensus: Patients note that starting with a movement disorder specialist in larger cities speeds up access to infusion trials. Many suggest tracking medication side effects closely to justify earlier switches to advanced therapies.
Warsaw, Krakow, and Rzeszow are the leading hubs for Parkinson’s care in Poland. These cities host major university hospitals and specialized centers. Facilities like University Hospital in Krakow provide advanced surgical interventions. These include deep brain stimulation (DBS) and MRgFUS for motor symptom management.
Bookimed Expert Insight: While Warsaw is the research hub, Krakow’s University Hospital is a massive clinical powerhouse. It employs over 1,000 doctors across 103 departments. This scale is vital for Parkinson’s because the disease requires multi-specialty coordination. Patients benefit from having neurologists, surgeons, and therapists in one 1,600-bed facility.
Patient Consensus: Patients note that public university hospitals offer the most advanced surgery. Many choose to pay privately to skip the standard 6-month wait times.
Advanced device-aided therapies in Poland are partially reimbursed via the Specialist Therapeutic Programme. Deep Brain Stimulation (DBS) is fully covered for eligible patients. Infusion therapies like Levodopa-Carbidopa receive medication reimbursement. Patients often pay out-of-pocket for delivery pumps or newer lightweight devices.
Bookimed Expert Insight: Poland's high patient volume at centers like University Hospital in Krakow creates significant waiting lists for reimbursed DBS. While 82 clinics operate in Poland, advanced device therapies remain concentrated in major academic hubs. Patients often choose private treatment or travel to nearby Germany for faster access to the latest infusion pump technology.
Patient Consensus: Patients note that public system approval requires meticulous documentation of oral medication failures. Many describe traveling to larger cities or seeking private options because infusion therapies remain rare in regional public hospitals.
Parkinson's patients in Poland face fragmented care characterized by severe regional disparities and limited access to advanced therapies. Specialist expertise is concentrated in major cities like Krakow and Rzeszow. Rural patients often struggle to find neurologists experienced in complex movement disorder management.
Bookimed Expert Insight: Patient volume data suggests a massive gap between general care and specialized neurology. While University Hospital in Krakow serves 455,000 patients annually, only a fraction of facilities handle complex neuro-rehabilitation. Patients should target multi-department centers in major cities. These hubs offer more diagnostic tools like DaTscans and EEG transition studies which smaller clinics lack.
Patient Consensus: Patients describe the system as a lottery where rural residents face significantly higher travel burdens. Many recommend budgeting for private consultations to bypass long queues and secure timely medication adjustments.